Literature DB >> 30817452

Normotensive patients with obstructive sleep apnoea: changes in 24-h ambulatory blood pressure monitoring with continuous positive airway pressure treatment.

Esther Sapiña-Beltrán1, Fernando Santamaria-Martos1, Ivan Benítez1, Gerard Torres1, Juan F Masa2,3, Manuel Sánchez-de-la-Torre1,2, Ferran Barbé1,2, Mireia Dalmases1,2.   

Abstract

BACKGROUND: Continuous positive airway pressure (CPAP) treatment reduces blood pressure (BP) in obstructive sleep apnoea (OSA) and hypertensive patients, but there is a lack of data about the effects of CPAP on the BP in normotensive patients.
OBJECTIVE: The aim of the study was to evaluate BP changes in normotensive OSA individuals receiving CPAP treatment.
METHODS: We selected 131 normotensive outpatients with an apnoea/hypopnoea index (AHI) greater than 15 events/hour who required CPAP treatment. All patients underwent a sleep study and 24-h ambulatory BP monitoring (ABPM) at baseline and after 6 months. In addition, the patients were assessed for the presence of baseline masked hypertension, defined as office BP less than 140/90 mmHg and increased BP on 24-h ABPM (mean 24-h BP ≥130/80 mmHg).
RESULTS: After 6 months of CPAP treatment, a mild reduction in all 24-h ABPM variables was observed, but only the mean 24-h DBP [-1.39 mmHg, 95% confidence interval (95% CI), -2.50 to -0.27], mean daytime DBP (-1.39 mmHg, 95% CI -2.56 to -0.22) and the mean 24-h ambulatory BP (-1.80 mmHg, 95% CI, -3.16 to -0.44) reached statistical significance. The reduction was primarily due to BP changes in individuals with masked hypertension who displayed a mean BP reduction of -4.78 mmHg (-7.25 to -2.30 mmHg). Consistent with a circadian BP pattern, a reduction in mean nocturnal BP of -4.73 mmHg (-7.39 to -2.06 mmHg) was observed at 6 months in nondippers; in contrast, the mean nocturnal BP in dippers increased by 2.61 mmHg (0.60-4.62 mmHg).
CONCLUSION: Our findings suggest that the CPAP effects may be different in normotensive outpatients depending on the presence of undiagnosed masked hypertension and the dipping pattern. Therefore, it is important to consider measuring ABPM in this type of patient.

Entities:  

Mesh:

Year:  2019        PMID: 30817452     DOI: 10.1097/HJH.0000000000001934

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  11 in total

Review 1.  Disturbed Sleep as a Mechanism of Race Differences in Nocturnal Blood Pressure Non-Dipping.

Authors:  Marissa A Bowman; Daniel J Buysse; Jillian E Foust; Vivianne Oyefusi; Martica H Hall
Journal:  Curr Hypertens Rep       Date:  2019-05-22       Impact factor: 5.369

2.  Effects of continuous positive airway pressure on blood pressure in obstructive sleep apnea patients: The Apnea Positive Pressure Long-term Efficacy Study (APPLES).

Authors:  Sogol Javaheri; Daniel J Gottlieb; Stuart F Quan
Journal:  J Sleep Res       Date:  2019-11-14       Impact factor: 3.981

3.  Non-dipping nocturnal blood pressure correlates with obstructive sleep apnoea severity in normotensive subjects and may reverse with therapy.

Authors:  Sophie J Crinion; Jana Kleinerova; Brian Kent; Geraldine Nolan; Cormac T Taylor; Silke Ryan; Walter T McNicholas
Journal:  ERJ Open Res       Date:  2021-08-16

Review 4.  Recent advances in the management of secondary hypertension-obstructive sleep apnea.

Authors:  Tomotake Tokunou; Shin-Ichi Ando
Journal:  Hypertens Res       Date:  2020-06-17       Impact factor: 3.872

5.  Pro: should asymptomatic patients with moderate-to-severe OSA be treated?

Authors:  Silke Ryan
Journal:  Breathe (Sheff)       Date:  2019-03

6.  Diurnal changes in central blood pressure and pulse pressure amplification in patients with obstructive sleep apnoea.

Authors:  Yasmina Serinel; Camilla Hoyos; Ahmad Qasem; Brendon J Yee; Ronald R Grunstein; Keith H Wong; Craig L Phillips
Journal:  Int J Cardiol Hypertens       Date:  2019-04-09

7.  An interesting link between quality of sleep and a measure of blood pressure variability.

Authors:  Kouichi Tamura; Kotaro Uchida; Tomoaki Ishigami
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-12-29       Impact factor: 3.738

Review 8.  Immunoregulatory Effect of Short-Chain Fatty Acids from Gut Microbiota on Obstructive Sleep Apnea-Associated Hypertension.

Authors:  Li Zhang; Chih-Yuan Ko; Yi-Ming Zeng
Journal:  Nat Sci Sleep       Date:  2022-03-10

9.  The Importance of Sleep Fragmentation on the Hemodynamic Dipping in Obstructive Sleep Apnea Patients.

Authors:  Richard Staats; Inês Barros; Dina Fernandes; Dina Grencho; Cátia Reis; Filipa Matos; João Valença; João Marôco; António Bugalho de Almeida; Cristina Bárbara
Journal:  Front Physiol       Date:  2020-03-13       Impact factor: 4.566

10.  Impact of patient and family engagement in improving continuous positive airway pressure adherence in patients with obstructive sleep apnea: a randomized controlled trial.

Authors:  Nazia Naz S Khan; David Todem; Shireesha Bottu; M Safwan Badr; Adesuwa Olomu
Journal:  J Clin Sleep Med       Date:  2022-01-01       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.